057429965	057429965	CD	B-NP	O
|	|	NN	I-NP	O
ICH	ICH	NN	I-NP	O
|	|	NN	I-NP	O
11802939	11802939	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6785209	6785209	CD	B-NP	O
|	|	CC	I-NP	O
3/22/2006	3/22/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
SEPSIS	SEPSIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/28/2006	10/28/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/18/2006	6/18/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
RAMINEZ	RAMINEZ	NN	B-NP	B-protein
,	,	,	O	O
ISRAEL	ISRAEL	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT	COMPLAINT	NNP	I-NP	O
:	:	:	O	O
Weakness	Weakness	NN	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
dizziness	dizziness	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
48-year-old	48-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
1/25/06	1/25/06	CD	B-NP	O
from	from	IN	B-PP	O
Nixma	Nixma	NNP	B-NP	O
County	County	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
after	after	IN	B-PP	O
an	an	DT	B-NP	O
ICU	ICU	NN	I-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
and	and	CC	I-NP	O
Klonopin	Klonopin	NN	I-NP	O
overdose	overdose	NN	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
here	here	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
becomes	become	VBZ	B-VP	O
dyspneic	dyspneic	JJ	B-ADJP	O
after	after	IN	B-PP	O
walking	walk	VBG	B-VP	O
20	20	CD	B-NP	O
feet	foot	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
obesity	obesity	NN	B-NP	O
and	and	CC	O	O
many	many	JJ	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
notes	note	VBZ	B-VP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
headache	headache	NN	B-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
questionable	questionable	JJ	I-NP	O
darkening	darkening	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
visual	visual	JJ	I-NP	O
fields	field	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
admits	admit	VBZ	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
p.o.	p.o.	NN	I-NP	O
intake	intake	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
rather	rather	RB	B-ADJP	O
poor	poor	JJ	I-ADJP	O
since	since	IN	B-PP	O
coming	come	VBG	B-VP	O
home	home	NN	B-ADVP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
anorexia	anorexia	NN	B-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
dehydrated	dehydrate	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
review	review	NN	B-NP	O
of	of	IN	B-PP	O
systems	system	NNS	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
also	also	RB	B-ADVP	O
notes	note	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
waxing	waxing	NN	I-NP	O
and	and	CC	O	O
waning	wan	VBG	B-VP	O
erythema	erythema	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
which	which	WDT	B-NP	O
in	in	IN	B-PP	O
recent	recent	JJ	B-NP	O
days	day	NNS	I-NP	O
has	have	VBZ	B-VP	O
worsened	worsen	VBN	I-VP	O
with	with	IN	B-PP	O
accompanying	accompany	VBG	B-VP	O
swelling	swelling	NN	B-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
her	her	PRP$	B-NP	O
son	son	NN	I-NP	O
says	say	VBZ	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
worse	worse	JJR	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
noted	note	VBN	I-VP	O
loose	loose	JJ	B-NP	O
stools	stool	NNS	I-NP	O
since	since	IN	B-PP	O
8/4/06	8/4/06	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
pleurisy	pleurisy	NN	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
stool	stool	NN	I-NP	O
or	or	CC	I-NP	O
urine	urine	NN	I-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
frequency	frequency	NN	B-NP	O
,	,	,	O	O
character	character	NN	B-NP	O
or	or	CC	I-NP	O
urination	urination	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
focal	focal	JJ	B-NP	O
weakness	weakness	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
new	new	JJ	I-NP	O
medications	medication	NNS	I-NP	O
other	other	JJ	B-ADJP	O
than	than	IN	B-PP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
antibiotic	antibiotic	JJ	I-NP	O
course	course	NN	I-NP	O
at	at	IN	B-PP	O
Dale	Dale	NNP	B-NP	O
Skin	Skin	NNP	I-NP	O
Sonmu	Sonmu	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
completed	complete	VBD	B-VP	O
there	there	RB	B-ADVP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
taken	take	VBN	I-VP	O
her	her	PRP$	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
or	or	CC	I-NP	O
methadone	methadone	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
sick	sick	JJ	I-NP	O
contact	contact	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
saw	see	VBD	B-VP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
on	on	IN	B-PP	O
2/8/06	2/8/06	CD	B-NP	O
who	who	WP	B-NP	O
found	find	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
hypoxic	hypoxic	JJ	I-ADJP	O
and	and	CC	O	O
then	then	RB	O	O
sent	send	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-PP	O
Ma	Ma	NNP	B-NP	O
County	County	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
ED	ED	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
family	family	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
not	not	RB	O	O
clear	clear	JJ	B-ADJP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
they	they	PRP	B-NP	O
report	report	VBP	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
kidney	kidney	NN	I-NP	O
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
abnormal	abnormal	JJ	B-ADJP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
dehydrated	dehydrate	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
admitted	admit	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
then	then	RB	B-ADVP	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
at	at	IN	B-PP	O
Town	Town	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
And	And	CC	O	O
Clinics	Clinics	NNP	B-NP	O
for	for	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
dizziness	dizziness	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
60	60	CD	I-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
110	110	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
30	30	CD	I-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
saturations	saturation	NNS	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
80	80	CD	I-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	I-NP	O
Levaquin	Levaquin	NN	I-NP	O
and	and	CC	I-NP	O
gentamicin	gentamicin	NN	I-NP	O
and	and	CC	O	O
3	3	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
saline	saline	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
aggressively	aggressively	RB	I-VP	O
given	give	VBN	I-VP	O
fluids	fluid	NNS	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Levophed	Levophe	VBN	B-VP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
support	support	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
low	low	JJ	B-NP	O
voltage	voltage	NN	I-NP	O
on	on	IN	B-PP	O
precordial	precordial	JJ	B-NP	O
leads	lead	NNS	I-NP	O
and	and	CC	O	O
borderline	borderline	JJ	B-NP	O
right	right	JJ	I-NP	O
axis	axis	NN	I-NP	O
deviation	deviation	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
otherwise	otherwise	RB	B-ADJP	O
clear	clear	JJ	I-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
,	,	,	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
stabilized	stabilize	VBN	I-VP	O
on	on	IN	B-PP	O
Levophed	Levophed	NNP	B-NP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
drop	drop	VB	I-VP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
70	70	CD	I-NP	O
's	's	POS	B-NP	O
when	when	WRB	B-ADVP	O
initiated	initiate	VBN	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
BiPAP	BiPAP	NN	I-NP	O
settings	setting	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
had	have	VBD	B-VP	O
endocarditis	endocarditis	NN	B-NP	O
20	20	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	JJ	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
BiPAP	BiPAP	NN	I-NP	O
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
ankle	ankle	NN	I-NP	O
injury	injury	NN	I-NP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
20	20	CD	I-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
motor	motor	NN	I-NP	O
vehicle	vehicle	NN	I-NP	O
accident	accident	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
ankle	ankle	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
right	right	RB	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
methadone	methadone	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
Klonopin	Klonopin	NNP	I-NP	O
overdose	overdose	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
Enterobacter	Enterobacter	NNP	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
cefepime	cefepime	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
questionable	questionable	JJ	B-ADVP	O
the	the	DT	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
questionable	questionable	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
COPD	COPD	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
extensive	extensive	JJ	I-NP	O
smoking	smoking	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
a	a	DT	B-NP	O
well	well	JJ	I-NP	O
state	state	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
PCO2	PCO2	NN	I-NP	B-protein
was	be	VBD	B-VP	O
49	49	CD	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
is	be	VBZ	B-VP	O
89	89	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	B-ADVP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
depression	depression	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	NN	I-NP	O
HOME	HOME	NN	I-NP	O
:	:	:	O	O
Lisinopril	Lisinopril	NN	B-NP	O
and	and	CC	I-NP	O
methadone	methadone	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
taking	take	VBG	I-VP	O
her	her	PRP$	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
taken	take	VBN	B-VP	O
lisinopril	lisinopril	NN	B-NP	O
with	with	IN	B-PP	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
allergic	allergic	JJ	B-ADJP	O
to	to	TO	B-PP	O
penicillin	penicillin	NN	B-NP	O
and	and	CC	I-NP	O
sulfa	sulfa	NN	I-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
smoked	smoke	VBD	B-VP	O
half	half	PDT	B-NP	O
a	a	DT	I-NP	O
pack	pack	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
30	30	CD	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
illicit	illicit	JJ	I-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
work	work	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
disability	disability	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
100	100	CD	I-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
130/80	130/80	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-ADJP	O
of	of	IN	B-PP	O
18	18	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
8	8	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
awake	awake	NN	B-NP	O
and	and	CC	I-NP	O
alert	alert	NN	I-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
anicteric	anicteric	JJ	B-ADJP	O
,	,	,	O	O
without	without	IN	B-PP	O
pallor	pallor	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
thick	thick	JJ	I-NP	O
neck	neck	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
and	and	CC	I-NP	O
crackles	crackle	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
tachy	tachy	JJ	B-ADJP	O
,	,	,	O	O
regular	regular	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
distant	distant	JJ	B-NP	O
S4	S4	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
difficulty	difficulty	NN	B-NP	O
to	to	TO	B-VP	O
ascertain	ascertain	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
neck	neck	NN	B-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
+	+	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nondistended	nondistended	JJ	I-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
were	be	VBD	B-VP	O
without	without	IN	B-PP	O
erythema	erythema	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
swelling	swelling	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
ankle	ankle	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ankles	ankle	NNS	I-NP	O
were	be	VBD	B-VP	O
without	without	IN	B-PP	O
swelling	swelling	NN	B-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
full	full	JJ	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
.	.	.	O	O

Neurologically	Neurologically	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
oriented	oriented	JJ	I-ADJP	O
,	,	,	O	O
but	but	CC	O	O
unfocused	unfocused	JJ	B-ADJP	O
in	in	IN	B-PP	O
conversation	conversation	NN	B-NP	O
,	,	,	O	O
moving	move	VBG	B-VP	O
all	all	PDT	B-NP	O
her	her	PRP$	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
strength	strength	NN	I-NP	O
was	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
STUDIES	STUDIES	VBZ	B-VP	O
ON	ON	NN	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
see	see	VB	B-VP	O
LMR	LMR	NN	B-NP	B-protein
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
AND	AND	CC	I-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
49-year-old	49-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
ICU	ICU	NN	I-NP	O
stay	stay	NN	I-NP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
,	,	,	O	O
tachycardia	tachycardia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Presentation	Presentation	NN	B-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
right	right	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolus	embolus	NN	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Pulmonary/Vascular	Pulmonary/Vascular	JJ	B-ADJP	O
:	:	:	O	O
There	There	EX	B-NP	O
was	be	VBD	B-VP	O
initial	initial	JJ	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
PE	PE	NN	I-NP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
presentation	presentation	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
hypotension	hypotension	NN	I-NP	O
,	,	,	O	O
tachycardia	tachycardia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Aa	Aa	NN	B-NP	O
gradient	gradient	NN	I-NP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
or	or	CC	O	O
primary	primary	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echo	echo	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
dilated	dilated	JJ	I-NP	O
RV	RV	NN	I-NP	O
with	with	IN	B-PP	O
depressed	depressed	JJ	B-NP	O
RV	RV	NN	I-NP	O
function	function	NN	I-NP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
PE	PE	NN	I-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
nondiagnostic	nondiagnostic	JJ	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
poorly	poorly	RB	B-NP	O
timed	time	VBN	I-NP	O
contrast	contrast	NN	I-NP	O
and	and	CC	I-NP	O
motion	motion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
VQ	VQ	NN	I-NP	O
scan	scan	NN	I-NP	O
showed	show	VBD	B-VP	O
intermediate	intermediate	JJ	B-NP	O
probability	probability	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
drip	drip	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
second	second	JJ	I-NP	O
PECT	PECT	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
PE	PE	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
large	large	JJ	B-ADJP	O
enough	enough	RB	I-ADJP	O
to	to	TO	B-VP	O
explain	explain	VB	I-VP	O
her	her	PRP$	B-NP	O
dramatic	dramatic	JJ	I-NP	O
presentation	presentation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
working	work	VBG	I-NP	O
hypothesis	hypothesis	NN	I-NP	O
is	be	VBZ	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
recanalization	recanalization	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
repeat	repeat	NN	I-NP	O
CT	CT	NN	I-NP	O
which	which	WDT	B-NP	O
took	take	VBD	B-VP	O
place	place	NN	B-NP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
CT.	CT.	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
never	never	RB	I-VP	O
intubated	intubate	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
face	face	NN	B-NP	O
mask	mask	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
upon	upon	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
4	4	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
O2	O2	NN	I-NP	O
saturations	saturation	NNS	I-NP	O
were	be	VBD	B-VP	O
acceptable	acceptable	JJ	B-NP	O
in-house	in-house	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
desaturate	desaturate	VB	I-VP	O
to	to	TO	B-PP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
took	take	VBD	B-VP	O
her	her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
off	off	IN	B-PP	O
a	a	DT	B-NP	O
night	night	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
multiple	multiple	JJ	B-NP	O
times	time	NNS	I-NP	O
refused	refuse	VBD	B-VP	O
BiPAP	BiPAP	NN	B-NP	B-protein
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
go	go	VB	I-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
it	it	PRP	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
returns	return	VBZ	B-VP	O
home	home	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
elevation	elevation	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
RV	RV	NN	B-NP	O
strain	strain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
severe	severe	JJ	B-NP	O
hypotension	hypotension	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
pressors	pressor	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
on	on	IN	B-PP	O
3/9/06	3/9/06	CD	B-NP	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
BiPAP	BiPAP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
little	little	JJ	I-NP	O
bit	bit	NN	I-NP	O
of	of	IN	B-PP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
dobutamine	dobutamine	NN	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
on	on	IN	B-PP	O
10/4/06	10/4/06	CD	B-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
hold	hold	VB	I-VP	O
her	her	PRP$	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
while	while	IN	B-SBAR	O
in-house	in-house	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
high	high	JJ	B-ADJP	O
enough	enough	RB	I-ADJP	O
to	to	TO	B-VP	O
withstand	withstand	VB	I-VP	O
on	on	IN	B-PP	O
additional	additional	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
lowering	lower	VBG	B-VP	O
medication	medication	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
discussed	discuss	VBN	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
perhaps	perhaps	RB	B-ADVP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
restarted	restart	VBD	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
failure	failure	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
6.9	6.9	CD	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
dropped	drop	VBD	B-VP	O
to	to	TO	B-PP	O
0.5	0.5	CD	B-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
prerenal	prerenal	JJ	B-NP	O
azotemia	azotemia	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
renal	renal	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
.	.	.	O	O

Hypoperfusion	Hypoperfusion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
kidneys	kidney	NNS	I-NP	O
in	in	IN	B-PP	O
setting	set	VBG	B-VP	O
of	of	IN	B-PP	O
hypovolemia	hypovolemia	NN	B-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
preload	preload	NN	I-NP	O
.	.	.	O	O

Mucomyst	Mucomyst	NN	B-NP	O
and	and	CC	I-NP	O
bicarb	bicarb	NN	I-NP	O
were	be	VBD	B-VP	O
given	give	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
PECTs	PECT	NNS	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
protection	protection	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
develop	develop	VB	I-VP	O
any	any	DT	B-NP	O
additional	additional	JJ	I-NP	O
contrast	contrast	NN	I-NP	O
nephropathy	nephropathy	NN	I-NP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
CT	CT	NN	I-NP	O
scans	scan	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
0.6	0.6	CD	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
cortisol	cortisol	NN	I-NP	O
level	level	NN	I-NP	O
with	with	IN	B-PP	O
ACTH	ACTH	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
were	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in-house	in-house	JJ	B-ADJP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
never	never	RB	B-ADVP	O
had	have	VBD	B-VP	O
any	any	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
supplemental	supplemental	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
house	house	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
empirically	empirically	RB	I-VP	O
covered	cover	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
and	and	CC	I-NP	O
gentamicin	gentamicin	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
given	give	VBN	I-VP	O
again	again	RB	B-ADVP	O
on	on	IN	B-PP	O
10/8/06	10/8/06	CD	B-NP	O
and	and	CC	O	O
on	on	IN	B-PP	O
2/8/06	2/8/06	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
infection	infection	NN	I-NP	O
found	find	VBN	B-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
differential	differential	JJ	I-NP	O
,	,	,	I-NP	O
normal	normal	JJ	I-NP	O
UA	UA	NNP	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
is	be	VBZ	B-VP	O
without	without	IN	B-PP	O
infiltrate	infiltrate	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
antibiotics	antibiotic	NNS	B-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
2/5/06	2/5/06	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
remain	remain	VB	I-VP	O
afebrile	afebrile	JJ	B-NP	O
in-house	in-house	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Urology	Urology	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
did	do	VBD	B-VP	O
complain	complain	NN	B-NP	O
of	of	IN	B-PP	O
bladder	bladder	NN	B-NP	O
spasms	spasm	NNS	I-NP	O
while	while	IN	B-SBAR	O
having	have	VBG	B-VP	O
the	the	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Ditropan	Ditropan	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
negative	negative	JJ	I-NP	O
urinalysis	urinalysis	NN	I-NP	O
and	and	CC	I-NP	O
urine	urine	NN	I-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
.	.	.	O	O

Once	Once	RB	O	O
the	the	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
void	void	VB	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
stopped	stop	VBD	B-VP	O
having	have	VBG	I-VP	O
bladder	bladder	NN	B-NP	O
spasms	spasm	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Monistat	Monistat	NNP	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
yeast	yeast	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Allergy	Allergy	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
eosinophilia	eosinophilia	NN	I-NP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
4	4	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
8	8	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2/5/06	2/5/06	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
7.5	7.5	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
allergy	allergy	NN	B-NP	O
,	,	,	O	O
rheumatic	rheumatic	JJ	B-NP	O
disease	disease	NN	I-NP	O
or	or	CC	O	O
parasitic	parasitic	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
obstructive	obstructive	JJ	I-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
asthma	asthma	NN	I-NP	O
variant	variant	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
inhaled	inhale	VBN	B-NP	O
corticosteroids	corticosteroid	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NNP	B-NP	B-protein
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
unfractionated	unfractionated	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
presumed	presumed	JJ	I-NP	O
PE	PE	NN	I-NP	O
until	until	IN	B-PP	O
2/5/06	2/5/06	CD	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
day	day	NN	I-NP	O
on	on	IN	B-PP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
subq	subq	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
157	157	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
,	,	,	O	O
her	her	PRP	B-NP	O
initially	initially	RB	B-VP	O
given	give	VBN	I-VP	O
10	10	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
2	2	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
7.5	7.5	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
at	at	IN	B-PP	O
2.5	2.5	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Lovenox	Lovenox	NNP	I-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
additional	additional	JJ	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Kid	Kid	NNP	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Psych/Addiction	Psych/Addiction	NN	B-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
are	be	VBP	B-VP	O
continuing	continue	VBG	I-VP	O
her	her	PRP$	B-NP	O
methadone	methadone	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
switched	switch	VBN	I-VP	O
from	from	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
little	little	JJ	I-NP	O
bit	bit	NN	I-NP	O
of	of	IN	B-PP	O
Ativan	Ativan	NNP	B-NP	O
while	while	IN	B-SBAR	O
in-house	in-house	NN	B-NP	O
to	to	TO	B-VP	O
help	help	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
agitation	agitation	NN	I-NP	O
and	and	CC	I-NP	O
anxiety	anxiety	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
little	little	JJ	I-NP	O
bit	bit	NN	I-NP	O
of	of	IN	B-PP	O
Haldol	Haldol	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
that	that	DT	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
1/29/06	1/29/06	CD	B-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
additional	additional	JJ	I-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
that	that	DT	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
central	central	JJ	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
10/18/06	10/18/06	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
2/5/06	2/5/06	CD	B-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
line	line	NN	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	B-PP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
problems	problem	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Social	Social	NNP	B-NP	O
Work	Work	NNP	I-NP	O
and	and	CC	O	O
PT	PT	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
refused	refuse	VBD	B-VP	O
to	to	TO	I-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
any	any	DT	B-NP	O
sort	sort	NN	I-NP	O
of	of	IN	B-PP	O
rehab	rehab	NN	B-NP	O
or	or	CC	I-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
return	return	VB	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
skilled	skilled	JJ	B-NP	O
nursing	nursing	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
PT	PT	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-6509749	8-6509749	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MCMAIN	MCMAIN	NNP	B-NP	O
,	,	,	O	O
MITCHELL	MITCHELL	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MCDUGLE	MCDUGLE	NNP	B-NP	O
,	,	,	O	O
VINCENZO	VINCENZO	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
5085941	5085941	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
11/12/06	11/12/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/12/06	11/12/06	CD	B-NP	O

